![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ARSE |
Gene summary for ARSE |
![]() |
Gene information | Species | Human | Gene symbol | ARSE | Gene ID | 415 |
Gene name | arylsulfatase L | |
Gene Alias | ARSE | |
Cytomap | Xp22.33 | |
Gene Type | protein-coding | GO ID | GO:0001501 | UniProtAcc | P51690 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
415 | ARSE | HTA11_3410_2000001011 | Human | Colorectum | AD | 3.26e-04 | -2.00e-01 | 0.0155 |
415 | ARSE | HTA11_78_2000001011 | Human | Colorectum | AD | 4.20e-02 | -2.00e-01 | -0.1088 |
415 | ARSE | HTA11_347_2000001011 | Human | Colorectum | AD | 9.99e-05 | -2.00e-01 | -0.1954 |
415 | ARSE | HTA11_696_2000001011 | Human | Colorectum | AD | 4.40e-09 | -2.00e-01 | -0.1464 |
415 | ARSE | HTA11_866_2000001011 | Human | Colorectum | AD | 9.55e-09 | -2.00e-01 | -0.1001 |
415 | ARSE | HTA11_1391_2000001011 | Human | Colorectum | AD | 6.84e-03 | -2.00e-01 | -0.059 |
415 | ARSE | HTA11_866_3004761011 | Human | Colorectum | AD | 2.14e-03 | -2.00e-01 | 0.096 |
415 | ARSE | HTA11_7696_3000711011 | Human | Colorectum | AD | 9.55e-09 | -2.00e-01 | 0.0674 |
415 | ARSE | HTA11_99999965104_69814 | Human | Colorectum | MSS | 4.21e-15 | 7.01e-01 | 0.281 |
415 | ARSE | HTA11_99999973899_84307 | Human | Colorectum | MSS | 9.37e-12 | 7.25e-01 | 0.2585 |
415 | ARSE | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.67e-14 | 6.08e-01 | 0.3005 |
415 | ARSE | A015-C-104 | Human | Colorectum | FAP | 1.70e-02 | 8.83e-02 | -0.1899 |
415 | ARSE | A002-C-116 | Human | Colorectum | FAP | 7.57e-04 | -3.45e-02 | -0.0452 |
415 | ARSE | CRC-3-11773 | Human | Colorectum | CRC | 1.08e-04 | -1.49e-01 | 0.2564 |
415 | ARSE | S43 | Human | Liver | Cirrhotic | 2.45e-05 | 1.19e-02 | -0.0187 |
415 | ARSE | HCC1_Meng | Human | Liver | HCC | 1.47e-77 | 1.78e-01 | 0.0246 |
415 | ARSE | HCC2_Meng | Human | Liver | HCC | 2.08e-19 | -1.32e-02 | 0.0107 |
415 | ARSE | cirrhotic1 | Human | Liver | Cirrhotic | 9.98e-12 | 3.13e-01 | 0.0202 |
415 | ARSE | cirrhotic2 | Human | Liver | Cirrhotic | 4.27e-08 | 1.82e-01 | 0.0201 |
415 | ARSE | HCC1 | Human | Liver | HCC | 6.73e-03 | 3.92e+00 | 0.5336 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ARSE | SNV | Missense_Mutation | c.245N>T | p.Gly82Val | p.G82V | protein_coding | deleterious(0.01) | possibly_damaging(0.699) | TCGA-AP-A056-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ARSE | SNV | Missense_Mutation | novel | c.1277C>T | p.Ala426Val | p.A426V | protein_coding | deleterious(0.01) | benign(0.173) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ARSE | SNV | Missense_Mutation | novel | c.494C>A | p.Thr165Asn | p.T165N | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ARSE | SNV | Missense_Mutation | c.406C>A | p.Arg136Ser | p.R136S | protein_coding | deleterious(0.04) | benign(0.429) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ARSE | SNV | Missense_Mutation | novel | c.346G>A | p.Ala116Thr | p.A116T | protein_coding | deleterious(0.04) | possibly_damaging(0.786) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ARSE | SNV | Missense_Mutation | c.164N>T | p.Ser55Phe | p.S55F | protein_coding | tolerated(0.62) | benign(0) | TCGA-AX-A0J0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
ARSE | SNV | Missense_Mutation | rs80338713 | c.1517C>T | p.Thr506Met | p.T506M | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AX-A1C4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
ARSE | SNV | Missense_Mutation | novel | c.431N>A | p.Ser144Tyr | p.S144Y | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD | |
ARSE | SNV | Missense_Mutation | rs80338713 | c.1517C>T | p.Thr506Met | p.T506M | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
ARSE | SNV | Missense_Mutation | c.164C>T | p.Ser55Phe | p.S55F | protein_coding | tolerated(0.62) | benign(0) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |